These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Transcatheter access route options for treatment of degenerated mitral valve prosthesis with a balloon-expandable biological valve.
    Author: Schaefer U, Frerker C, Bader R, Schmoeckel M, Busse C, Kuck KH.
    Journal: Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):999-1003. PubMed ID: 23008188.
    Abstract:
    OBJECTIVES: There is an ongoing discussion if valve-in-valve implantations into failing mitral xenografts should be performed only via a transapical approach. BACKGROUND: In selected high-risk patients, transcatheter valve implantation is an emerging therapy for degenerated mitral xenografts in need of repeated valve replacement. METHODS: Here we describe three different strategies to treat a failing mitral biological prosthesis (Carpentier Edwards S.A.V) by implantation of a SAPIEN-XT valve, which was performed in three different patients. As access site, a transjugular/transseptal approach, a transfemoral/transseptal approach, and a transapical approach were chosen. RESULTS: With all three approaches, valve-in-valve implantation was successfully achieved. The acute hemodynamic effects were excellent and according to VARC there was no adverse event recorded during a 6 months follow-up. CONCLUSIONS: Feasibility of all three approaches is demonstrated and might be taken into consideration for treatment in various patients.
    [Abstract] [Full Text] [Related] [New Search]